Anthony Chilton

Tony has over 30 years of experience in the pharmaceutical industry with 20 years in senior leadership roles in biotech, large pharma, and contract research organizations. Primarily working in drug discovery, preclinical and early clinical phase development, gaining operational and regulatory experience in Canada, US and Europe. As the President/CEO of a midsize public traded multinational CRO, led a successful reorganization and expansion of the company.

As a consultant, Tony has worked on a variety of drug development programs, managing programs and milestones and resolving issues in discovery through IND projects, including programs for Cystic Fibrosis, pediatric renal disease, atherosclerosis and diabetes. Tony co-developed a novel sterile formulation, to support oncology clinical trials. Tony obtained his honours degree in Chemistry from the University of East Anglia and his PhD with the University of Hertfordshire.